Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Filings indexed 705 across all filing types
Latest filing 2024-04-25 Call Transcript
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document is a short letter addressed to stock exchanges regarding the audio recording of the Q4 FY24 results conference call. It references the conference call and provides a web link to the audio recording, but does not contain the transcript or detailed financial data itself. The document length is only 1243 characters, which is quite short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement about the availability of a conference call recording, not the transcript or the earnings release itself. Therefore, the appropriate classification is 'Call Transcript (CT)' because it relates to the conference call, but since it only announces the audio recording and does not provide the transcript, the best fit is the announcement related to the call. However, since there is no transcript text, and it is only an announcement of the audio recording, the closest category is Regulatory Filings (RNS) as a fallback for miscellaneous announcements that do not fit other categories. But given the document's nature and the specific mention of the conference call, the classification is 'Call Transcript (CT)' with moderate confidence, acknowledging it is not the full transcript but related to the call.
2024-04-25 English
Book Closure
Regulatory Filings Classification · 95% confidence The document is a formal communication from Laurus Labs Limited to stock exchanges regarding the closure of the register of members and share transfer books for the purpose of the upcoming Annual General Meeting (AGM). It specifies the book closure dates and the AGM date, but does not contain any financial data, report content, or detailed meeting materials. The document is short (1815 characters) and serves as an announcement related to the AGM, specifically about administrative arrangements (book closure). This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement that does not fit into more specific categories like AGM Information or Annual Report. It is not a report itself, nor a voting result or proxy solicitation. Therefore, the best classification is Regulatory Filings (RNS).
2024-04-25 English
Record Date
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from the company's Board of Directors regarding the approval of a second interim dividend for the financial year 2023-24. It specifies the dividend amount, record date, and payment date. The document is only 1418 characters long and serves as a notification to stock exchanges. It does not contain financial statements or detailed financial analysis. Therefore, it is an announcement of dividend payment details, fitting the category of Notice of Dividend Amount (DIV).
2024-04-25 English
Change in Director(s)
Regulatory Filings
2024-04-25 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a press release dated April 25, 2024, announcing the financial results for the quarter and full year ended March 31, 2024, for Laurus Labs Limited. It contains detailed financial highlights including revenue, EBITDA, PAT, EPS, and segment-wise business performance. It also includes commentary from the CEO and CFO, business highlights, and changes in the board of directors. The document is about quarterly and full-year financial results with substantive financial data and analysis, not just a brief announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Although it includes some board changes, the primary content is financial results, so the classification should be IR rather than MANG. The document length (over 14,000 characters) supports it being a full report rather than a short announcement.
2024-04-25 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a detailed presentation addressed to stock exchanges and investors, dated April 25, 2024, concerning the standalone and consolidated financial results for the quarter and year ended March 31, 2024. It includes a comprehensive agenda covering corporate overview, financial overview, business review, strategy, and outlook. The content includes forward-looking statements, financial metrics, business updates, board reorganization details, and ESG information. The document is explicitly described as an "Investors/Analysts Presentation" and is intended for an investor call. It is not a full annual or quarterly report but a presentation summarizing financial results and business strategy for investors and analysts. Therefore, the document fits the category of an Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2024-04-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.